Clinical data analysis platform Shyft has agreed to a $195m purchase by investor Medidata that will also allow McKesson and UnitedHealth to exit.
Medical research technology provider Medidata agreed last month to acquire US-based life sciences analytics platform Shyft Analytics for $195m, having invested in the company in 2016.
Shyft has developed a cloud-based platform that enables pharmaceutical and biotech researchers to drive relevant information from large amounts of complex data.
Medidata owned a 6% stake in Shyft pre-acquisition, after taking part in the first tranche of a series B round that closed at $20m in March 2017 with participation from…
